|
Name |
Xenoacremone F
|
Molecular Formula | C30H37NO6 | |
IUPAC Name* |
13-ethenyl-12,16-dihydroxy-19-methoxy-5,7-dimethyl-2-oxa-18-azahexacyclo[19.2.2.13,10.116,19.04,9.014,27]heptacosa-1(23),11,21,24-tetraene-15,17-dione
|
|
SMILES |
C=CC1C(O)=CC2C3CC(C)CC(C)C3C3Oc4ccc(cc4)CC4(OC)CC(O)(C(=O)N4)C(=O)C1C23
|
|
InChI |
InChI=1S/C30H37NO6/c1-5-19-22(32)12-21-20-11-15(2)10-16(3)23(20)26-24(21)25(19)27(33)30(35)14-29(36-4,31-28(30)34)13-17-6-8-18(37-26)9-7-17/h5-9,12,15-16,19-21,23-26,32,35H,1,10-11,13-14H2,2-4H3,(H,31,34)/t15-,16+,19-,20+,21-,23-,24+,25-,26-,29-,30-/m1/s1
|
|
InChIKey |
WBFMYBCGTPDUHH-JYHDLTQLSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 507.63 | ALogp: | 3.6 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 105.1 | Aromatic Rings: | 7 |
Heavy Atoms: | 37 | QED Weighted: | 0.407 |
Caco-2 Permeability: | -4.815 | MDCK Permeability: | 0.00001720 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.507 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.08 |
Blood-Brain-Barrier Penetration (BBB): | 0.375 | Plasma Protein Binding (PPB): | 98.18% |
Volume Distribution (VD): | 1.939 | Fu: | 1.77% |
CYP1A2-inhibitor: | 0.027 | CYP1A2-substrate: | 0.899 |
CYP2C19-inhibitor: | 0.752 | CYP2C19-substrate: | 0.893 |
CYP2C9-inhibitor: | 0.746 | CYP2C9-substrate: | 0.951 |
CYP2D6-inhibitor: | 0.218 | CYP2D6-substrate: | 0.409 |
CYP3A4-inhibitor: | 0.891 | CYP3A4-substrate: | 0.914 |
Clearance (CL): | 10.022 | Half-life (T1/2): | 0.029 |
hERG Blockers: | 0.397 | Human Hepatotoxicity (H-HT): | 0.317 |
Drug-inuced Liver Injury (DILI): | 0.188 | AMES Toxicity: | 0.675 |
Rat Oral Acute Toxicity: | 0.884 | Maximum Recommended Daily Dose: | 0.943 |
Skin Sensitization: | 0.082 | Carcinogencity: | 0.071 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.004 |
Respiratory Toxicity: | 0.242 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005135 | 0.591 | D0VA0I | 0.234 | ||||
ENC005770 | 0.579 | D01XWG | 0.212 | ||||
ENC005769 | 0.579 | D01XDL | 0.211 | ||||
ENC005766 | 0.578 | D0W2EK | 0.209 | ||||
ENC005767 | 0.522 | D06OMK | 0.206 | ||||
ENC005320 | 0.515 | D0I5DS | 0.205 | ||||
ENC003606 | 0.486 | D06WTZ | 0.204 | ||||
ENC005366 | 0.486 | D0U7GP | 0.203 | ||||
ENC003349 | 0.482 | D01JGV | 0.203 | ||||
ENC003137 | 0.460 | D0H0ND | 0.201 |